MAGIC: once upon a time in consent management$da FHIR® tale

The use of medical data for research purposes requires an informed consent of the patient that is compliant with the EU General Data Protection Regulation. In the context of multi-centre research initiatives and a multitude of clinical and epidemiological studies scalable and automatable measures fo...

Full description

Saved in:
Bibliographic Details
Main Authors: Bialke, Martin (Author) , Tremper, Galina (Author) , Lablans, Martin (Author) , Ückert, Frank (Author)
Format: Article (Journal)
Language:English
Published: 14 September 2018
In: Journal of translational medicine
Year: 2018, Volume: 16, Pages: 1-11
ISSN:1479-5876
DOI:10.1186/s12967-018-1631-3
Online Access:Verlag, Volltext: http://dx.doi.org/10.1186/s12967-018-1631-3
Verlag, Volltext: https://doi.org/10.1186/s12967-018-1631-3
Get full text
Author Notes:Martin Bialke, Thomas Bahls, Lars Geidel, Henriette Rau, Arne Blumentritt, Sandra Pasewald, Robert Wolff, Jonas Steinmann, Tobias Bronsch, Björn Bergh, Galina Tremper, Martin Lablans, Frank Ückert, Stefan Lang, Tarik Idris and Wolfgang Hoffmann
Description
Summary:The use of medical data for research purposes requires an informed consent of the patient that is compliant with the EU General Data Protection Regulation. In the context of multi-centre research initiatives and a multitude of clinical and epidemiological studies scalable and automatable measures for digital consent management are required. Modular form, structure, and contents render a patient’s consent reusable for varying project settings in order to effectively manage and minimise organisational and technical efforts.
Item Description:Gesehen am 05.02.2019
Physical Description:Online Resource
ISSN:1479-5876
DOI:10.1186/s12967-018-1631-3